Recreational drug use among individuals living with HIV in Europe: review of the prevalence, comparison with the general population and HIV guidelines recommendations
Por:
Garin N, Velasco C, De Pourcq JT, Lopez B, Gutierrez Mdel M, Haro JM, Feliu A, Mangues MA and Trilla A
Publicada:
14 jul 2015
Categoría:
Microbiology (medical)
Resumen:
Adherence problems, interactions and higher rate of risk activities have been observed in HIV individuals using recreational drugs. Our aim was to describe recreational drug use in both HIV individuals and general population in Europe, and to assess at what extent HIV guidelines address this issue.
Filiaciones:
Garin N:
Pharmacy Department, Institut d'Investigacions Biomèdiques Sant Pau, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona Barcelona, Spain
Research and Development Unit, Parc Sanitari Sant Joan de Déu, University of Barcelona Barcelona, Spain
Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III Madrid, Spain
Velasco C:
Department of Preventive Medicine and Epidemiology, Hospital Clinic-IDIBAPS, University of Barcelona Barcelona, Spain
ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic - Universitat de Barcelona Barcelona, Spain
Lopez B:
Pharmacy Department, Hospital del Mar - Parc de Salut Mar Barcelona, Spain
Gutierrez Mdel M:
Grup de Recerca en HIV i AIDS-IR, Hospital de la Santa Creu i Sant Pau Barcelona, Spain
Haro JM:
Research and Development Unit, Parc Sanitari Sant Joan de Déu, University of Barcelona Barcelona, Spain
Centro de Investigación Biomédica en Red de Salud Mental, Instituto de Salud Carlos III Madrid, Spain
Trilla A:
Department of Preventive Medicine and Epidemiology, Hospital Clinic-IDIBAPS, University of Barcelona Barcelona, Spain
ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clínic - Universitat de Barcelona Barcelona, Spain
Open Access
|